MannKind Corp
NASDAQ:MNKD

Watchlist Manager
MannKind Corp Logo
MannKind Corp
NASDAQ:MNKD
Watchlist
Price: 7.02 USD 0.86% Market Closed
Market Cap: 1.9B USD
Have any thoughts about
MannKind Corp?
Write Note

MannKind Corp
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MannKind Corp
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
MannKind Corp
NASDAQ:MNKD
Total Current Liabilities
$72.1m
CAGR 3-Years
13%
CAGR 5-Years
2%
CAGR 10-Years
-13%
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$43.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$11.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$20.3B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$4B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.7B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
24%

See Also

What is MannKind Corp's Total Current Liabilities?
Total Current Liabilities
72.1m USD

Based on the financial report for Sep 30, 2024, MannKind Corp's Total Current Liabilities amounts to 72.1m USD.

What is MannKind Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-13%

Over the last year, the Total Current Liabilities growth was -25%. The average annual Total Current Liabilities growth rates for MannKind Corp have been 13% over the past three years , 2% over the past five years , and -13% over the past ten years .

Back to Top